United Therapeutics Corporation Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings
United Therapeutics Corporation (UTHR) reported Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings of $1.90 million for the 12-month period ending 2010-12-31, per its 10-K filed 2012-02-28.
Discontinued › Income Statement › Other Income
us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings · last filed 2012-02-28
- United Therapeutics Corporation fair value, assets and liabilities measured on recurring basis, gain (loss) included in earnings for fiscal 2010 was $1.90M.
| Period end | Fair Value, Assets and Liabilities Measured on Recurring Basis, Gain (Loss) Included in Earnings 12 month |
|---|---|
| 2010-12-31 | $1.90M 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |